Revolutionizing Cancer Research: EUCAIM unveils first release of groundbreaking platform to fuel collaborative innovation and data sharing across Europe

The EUCAIM consortium and the European Commission are excited to announce the first public release of its platform, Cancer Image Europe, marking a major milestone in the project’s development and an exciting step towards achieving its vision and goals. The first platform release benefits researchers, clinicians and AI innovators across Europe and paves the way […]

ChAImeleon Open Challenge: participate!

Take the opportunity of an EU-wide project to showcase your skills and expertise, and help us develop innovative AI-powered solutions for cancer management. Clinical problem In light of the growing need for new strategies to enhance cancer treatment management, we are excited to announce an open challenge aimed at addressing this critical issue. With 3.7 […]

Launch of the European Cancer Imaging Initiative

The European Cancer Imaging Initiative aims to advance innovation and deployment of digital technologies in cancer treatment and care, to achieve more precise and faster clinical decision-making, diagnostics and treatments. The European Cancer Imaging Initiative is one of the flagships of the EBCP, Europe’s Beating Cancer Plan, which endeavors to make the most of the potential of […]

Medexprim wishes you a caring, innovative, ambitious and collaborative new year!

2022 has been a rewarding year for Medexprim , with many challenges, distinctions, and the integration of twice as many talents into our team: 2022 video In 2023, our values will serve as a compass for the next stage of our growth: ambition, cooperation, care, innovation. Our ambition remains the same: improve the efficiency of […]

PR – Innovative partnership between Clinique Saint-Augustin, SurgAR, Medexprim – Augmented reality for laparoscopic surgery

Clinique Saint Augustin in Bordeaux, France, SurgAR and Medexprim are proud to announce a 4-year strategic partnership to accelerate the development of SurgAR’s augmented reality software dedicated to robot-assisted laparoscopic partial nephrectomy.   A member of the Elsan group and leader in private hospitalization in France, the Saint Augustin Clinic in Bordeaux has 111 practitioners, including […]

PR – Medexprim identified as “Key Innovator” by the European Commission

The European Commission’s Innovation Radar has identified Medexprim as “Key Innovator” for its distinctive role in the H2020 PRIMAGE project. The Primage project proposes an open cloud-based platform to support decision making in the clinical management of two paediatric cancers (Neuroblastoma and the Diffuse Intrinsic Pontine Glioma). It involves internationally recognized researchers in in-silico technologies […]

PR – Medexprim laureate of the Digital Health Scale Up 2025 Program

Medexprim has been selected to join the Digital Health Scale-Up 2025 program to accelerate its internationalization in Europe. On April 6, the Digital Health Scale-Up 2025 program was launched, an initiative organized under the French presidency of the Council of the European Union, carried out by the French Healthcare Association, BpiFrance, EIT Health and AI […]

PR – Medexprim strenghtens its team by recruiting Thomas Josse as Customer Success Director

Medexprim has welcomed Thomas Josse as Customer Success Director to reinforce its Delivery and Support teams. Thomas will be responsible for the smooth running of service activities and customer satisfaction on the missions he will supervise. Fabrice Pillon, General Manager of Customer Success: “We want to offer all our customers and partners access to excellent […]

PR – Medexprim joins the first class of PariSanté Campus

Medexprim has joined the first class of the scientific interest group PariSanté Campus, composed of 60 startups representing the best of digital health in France, to stimulate the exploitation of health data for research, innovation, and care. PariSanté Campus is part of the government’s overall strategy “to strengthen the resources dedicated to research and innovation […]